NLRP3 Inflammasome Inhibitor Ameliorates Amyloid Pathology in a Mouse Model of Alzheimer's Disease.

about

The IL-1β phenomena in neuroinflammatory diseases.Mfn2 ablation causes an oxidative stress response and eventual neuronal death in the hippocampus and cortex.Modulation of mitochondrial bioenergetics as a therapeutic strategy in Alzheimer's disease.

P2860

Q39324087-246EC969-C39A-4F0C-826C-53162F2A6DCD Q48042283-087DA84B-C80C-4668-AD1A-7FDB62FEEC38 Q49940144-DB8E69C4-F74B-457E-9DC4-23103768D3BD

P2860

NLRP3 Inflammasome Inhibitor Ameliorates Amyloid Pathology in a Mouse Model of Alzheimer's Disease.

Item

http://www.wikidata.org/entity/Q38931725

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

NLRP3 Inflammasome Inhibitor A ...... Model of Alzheimer's Disease.

@en

type

Item

label

NLRP3 Inflammasome Inhibitor A ...... Model of Alzheimer's Disease.

@en

prefLabel

NLRP3 Inflammasome Inhibitor A ...... Model of Alzheimer's Disease.

@en

P1476

NLRP3 Inflammasome Inhibitor A ...... e Model of Alzheimer's Disease

@en

P2093

Fanpeng Zhao

http://www.w3.org/2001/XMLSchema#string

Jacob Fulp

http://www.w3.org/2001/XMLSchema#string

Jun Yin

http://www.w3.org/2001/XMLSchema#string

Shijun Zhang

http://www.w3.org/2001/XMLSchema#string

William L Klein

http://www.w3.org/2001/XMLSchema#string

P2860

Variant of TREM2 Associated with the Risk of Alzheimer's Disease

The inflammasomes

NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice

Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice

The amyloid hypothesis of Alzheimer's disease at 25 years

Neuronal failure in Alzheimer's disease: a view through the oxidative stress looking-glass

NLRP3 inflammasome and its inhibitors: a review

Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent models

R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study

Parkinson's disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes

P2888

s12035-017-0467-9

P304

1977-1987

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12035-017-0467-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jeremy E Chojnacki

Xiongwei Zhu

P577

2017-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084033860

http://www.w3.org/2001/XMLSchema#string

P698

28255908

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

inflammasome

P932

5585057

http://www.w3.org/2001/XMLSchema#string

NLRP3 Inflammasome Inhibitor Ameliorates Amyloid Pathology in a Mouse Model of Alzheimer's Disease.

about

P2860

P2860

NLRP3 Inflammasome Inhibitor Ameliorates Amyloid Pathology in a Mouse Model of Alzheimer's Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932